Intravitreal Injection of Allogeneic Human Retinal Progenitor Cells (hRPC) for Treatment of Retinitis Pigmentosa: A Prospective Randomized Controlled Phase 2b Trial
2021
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI